Overview
Bong-hae Cho practices practicing medicine in Yangsan, Republic of Korea.
Cho is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Oral Cancer, Burkitt Lymphoma, Fibromatosis, and Osteotomy.
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Bong-hae Cho
Is Bong-hae Cho a top-rated expert for Oral Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Bong-hae Cho is classified as an Advanced expert for Oral Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Bong-hae Cho participate in research or clinical trials?
Yes. Bong-hae Cho has published 29 articles and abstracts on conditions like Oral Cancer. You can view a list of Bong-hae Cho's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Oral CancerCho isAdvanced. Learn about Oral Cancer.
- Experienced
- Burkitt LymphomaCho isExperienced. Learn about Burkitt Lymphoma.
- FibromatosisCho isExperienced. Learn about Fibromatosis.
- OsteotomyCho isExperienced. Learn about Osteotomy.